North America Archives - Page 17 of 39 - Journal for Clinical Studies

Current Edition

Europe

Setting Standards: Achieving Workforce Excellence

New Case Study Unveils Successful Approach to Enhancing Clinical Research Processes Maidenhead, 27 February 2019 -- New steps to achieving clinical research workfo...

28 February 2019 Europe | news | North America | Regional News

Continue Reading →

news

Clinical trial researchers can initiate advance care planning discussions to help cancer patients

Cancer clinical trials are an important option for patients with cancer. Yet, once a trial ends, patients still need care plans. Little is known at what point during...

20 February 2019 news | North America | Regional News

Continue Reading →

news

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, the...

20 February 2019 news | North America | Regional News

Continue Reading →

news

Use of clinical apps significantly improves quality of cardiovascular care

A pilot program using several clinical decision support tools in the outpatient setting to treat and educate stable ischemic heart disease patients has shown succes...

20 February 2019 news | North America | Regional News

Continue Reading →

news

Ochsner Health System and Pfizer partner to develop innovative models for clinical trials

NEW ORLEANS & Ochsner Health System, Louisiana's largest non-profit academic healthcare system, and Pfizer Inc (NYSE:PFE) have entered into a multi-year strateg...

20 February 2019 news | North America | Regional News

Continue Reading →

Europe

Orion’s and Bayer’s darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial

American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019: Orion's and Bayer's darolutamide plus androgen deprivation therapy (A...

20 February 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

New Clinerion And Citeline Partnership Simplifies and Strengthens Matchmaking Between Clinical Researchers and Qualified Patients

Collaboration between two companies leads to more informed decisions for clinical researchers, grounded in real-world evidence. Citeline, part of the Informa Pharm...

20 February 2019 Europe | news | North America | Regional News

Continue Reading →

news

Despite Phase III failure, Gilead’s selonsertib may still have place in NASH combination therapy strategy, says GlobalData

Despite its failure in the Phase III STELLAR-4 trial, Gilead Sciences’ lead non-alcoholic steatohepatitis (NASH) drug candidate, selonsertib, may still have a pla...

20 February 2019 news | North America | Regional News

Continue Reading →

Europe

Merck plans trio of Phase 3 Keytruda studies in prostate cancer

Merck & Co. said Thursday it plans to launch three pivotal Phase 3 studies testing different combination therapies involving its blockbuster immunotherapy Keytru...

20 February 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Merck’s Keytruda set to become new standard of care for renal cancer patient population after gaining edge over competitors, says GlobalData

Merck & Co Inc’s abstract presentation regarding KEYNOTE-426 trial at ASCO GU 2019 (16 February 2019) has confirmed that Keytruda, an anti-PD-1 therapy, in combi...

20 February 2019 Europe | news | North America | Regional News

Continue Reading →